Encoded Therapeutics

Drug Discovery

Encoded Therapeutics is a private drug discovery company. It was valued at $1.8 billion at its Series F in Sep 2026, the last priced event on record. It has raised $275 million across 2 recorded rounds; the latest was a $275 million Series F in Sep 2026.

PMV mark · valuation
$1.8B
Oct 2026
Priced at
its Series F
Sep 2026
Total raised
$275.0M
Last round
Series F
Sep 2026
What is Encoded Therapeutics worth?
$1.8BPrivateMarketView mark · Oct 2026

Valued at $1.8B at its Series F, Sep 2026. Nothing has traded since.

Free account
More of Encoded Therapeutics with a free account
  • ·The post-money valuation on its round
  • ·Watch Encoded Therapeutics: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Valuation timeline

1 priced round · 32 daily marks since · Sep 2026 – Oct 2026
▮▮
Series Frounds hold their value until the next priced eventMark, today
log scale
Post-money values unlock with a free account.Unlock the axis

Membership and data by Private Market View

Encoded Therapeutics funding history

2 rounds
DateRoundRaisedPost-money
Sep 2026Series F$275.0M▮
Apr 2017Accelerator/Incubator—▮
Unlock post-money valuations

Membership and data by Private Market View

Encoded Therapeutics valuation

Encoded Therapeutics was valued at $1.8 billion at its Series F in Sep 2026. That is the last priced event on record: no secondary trade or institutional fund mark has moved the figure since.

Recent activity

In the last 90 days, Encoded Therapeutics's record added 1 funding round.

How much has Encoded Therapeutics raised?

Encoded Therapeutics has raised $275 million across 2 recorded rounds since 2017. The largest was a $275 million Series F in Sep 2026. 1 of the rounds disclosed a post-money valuation.

Comparable companies

Comparable drug discovery names by valuation on PrivateMarketView: Formation Bio ($1.7 billion), Areteia Therapeutics ($1.3 billion) and Neurona Therapeutics ($1.1 billion).

How Encoded Therapeutics's valuation is determined

Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.

For Encoded Therapeutics, the most current credible signal sets the number and the older ones confirm it: a live secondary-market price first, then three or more recent prints, then institutional fund marks, and otherwise the last priced round, which never decays. The valuation is the last round’s post-money moved by the price change since that round, so no share count is assumed. Today it is set by its last priced round. Question about this number? Full methodology →

Frequently asked about Encoded Therapeutics

What is Encoded Therapeutics worth?
Encoded Therapeutics is valued at $1.8B as of Oct 2026. Valued at $1.8B at its Series F, Sep 2026. Nothing has traded since.
How much has Encoded Therapeutics raised?
Encoded Therapeutics has raised $275.0M in total funding across 2 recorded rounds.
When did Encoded Therapeutics last raise?
Encoded Therapeutics last raised in Sep 2026 (Series F), raising $275.0M.